EP0633781A4 - Zusammensetzungen und verfahren zur behandlung der benignen prostatahypertropie. - Google Patents

Zusammensetzungen und verfahren zur behandlung der benignen prostatahypertropie.

Info

Publication number: EP0633781A4
Authority: EP; European Patent Office
Prior art keywords: compositions; methods; benign prostatic; prostatic hypertrophy; treating benign
Prior art date: 1992-04-02
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP93908738A

Other languages

English (en)

French (fr)

Other versions

EP0633781A1 (de

Inventor

Jacob Paul Hieble

Brian Walter Metcalf

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SmithKline Beecham Corp

Original Assignee

SmithKline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-04-02

Filing date

1993-04-02

Publication date

1995-04-19

1993-04-02 Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp

1995-01-18 Publication of EP0633781A1 publication Critical patent/EP0633781A1/de

1995-04-19 Publication of EP0633781A4 publication Critical patent/EP0633781A4/de

Status Withdrawn legal-status Critical Current

Links

206010004446 Benign prostatic hyperplasia Diseases 0.000 title 1
208000004403 Prostatic Hyperplasia Diseases 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Steroid Compounds (AREA)
Medicines Containing Plant Substances (AREA)

EP93908738A 1992-04-02 1993-04-02 Zusammensetzungen und verfahren zur behandlung der benignen prostatahypertropie. Withdrawn EP0633781A4 (de)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US86211792A	1992-04-02	1992-04-02
US862117		1992-04-02
US99779292A	1992-12-29	1992-12-29
US997792		1992-12-29
PCT/US1993/003145 WO1993019758A1 (en)	1992-04-02	1993-04-02	Compositions and methods for treating benign prostatic hypertrophy

Publications (2)

Publication Number	Publication Date
EP0633781A1 EP0633781A1 (de)	1995-01-18
EP0633781A4 true EP0633781A4 (de)	1995-04-19

Family

ID=27127672

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP93908738A Withdrawn EP0633781A4 (de)	1992-04-02	1993-04-02	Zusammensetzungen und verfahren zur behandlung der benignen prostatahypertropie.

Country Status (8)

Country	Link
EP (1)	EP0633781A4 (de)
JP (1)	JPH07505398A (de)
KR (1)	KR950700746A (de)
AU (1)	AU668157B2 (de)
CA (1)	CA2133440A1 (de)
MX (1)	MX9301939A (de)
NZ (1)	NZ251658A (de)
WO (1)	WO1993019758A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL101243A (en) *	1991-03-20	1999-12-22	Merck & Co Inc	Pharmaceutical preparations for the treatment of benign prostatic hyperplasia containing steroid history
AU7719894A (en) *	1993-09-03	1995-03-22	Smithkline Beecham Corporation	Stabilized tablet formulation
WO1995028397A1 (en) *	1994-04-14	1995-10-26	Merck & Co., Inc.	Alpha1c adrenergic receptor antagonists
US5543417A (en) *	1994-10-21	1996-08-06	Merck & Co., Inc.	Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
US5595996A (en) *	1994-10-25	1997-01-21	Merck & Co., Inc.	7-substituted 4-aza cholanic acid derivatives and their use
US5952003A (en) *	1996-08-01	1999-09-14	Novartis Corporation	Terazosin capsules
CA2808219C (en)	2010-09-02	2019-05-14	Gruenenthal Gmbh	Tamper resistant dosage form comprising inorganic salt

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1992016213A1 (en) *	1991-03-20	1992-10-01	Merck & Co., Inc.	Pharmaceutical combination for the treatment of prostatic hyperplasia, containing a 5 alpha-reductase inhibitor and an antiandrogen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA883034B (en) *	1987-04-29	1989-03-29	Smithkline Beckman Corp	Steroid 5-alpha-reductase inhibitors
US4963547A (en) *	1988-06-01	1990-10-16	Smithkline Beecham Corporation	Alpha-andrenergic receptor antagonists and use thereas
US5308832A (en) *	1992-07-27	1994-05-03	Abbott Laboratories	Nutritional product for persons having a neurological injury

1993
- 1993-04-02 MX MX9301939A patent/MX9301939A/es unknown
- 1993-04-02 JP JP5517741A patent/JPH07505398A/ja active Pending
- 1993-04-02 NZ NZ251658A patent/NZ251658A/en unknown
- 1993-04-02 EP EP93908738A patent/EP0633781A4/de not_active Withdrawn
- 1993-04-02 WO PCT/US1993/003145 patent/WO1993019758A1/en not_active Ceased
- 1993-04-02 CA CA002133440A patent/CA2133440A1/en not_active Abandoned
- 1993-04-02 AU AU39451/93A patent/AU668157B2/en not_active Ceased
1994
- 1994-10-04 KR KR1019940703522A patent/KR950700746A/ko not_active Withdrawn

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1992016213A1 (en) *	1991-03-20	1992-10-01	Merck & Co., Inc.	Pharmaceutical combination for the treatment of prostatic hyperplasia, containing a 5 alpha-reductase inhibitor and an antiandrogen

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9319758A1 *

Also Published As

Publication number	Publication date
EP0633781A1 (de)	1995-01-18
AU3945193A (en)	1993-11-08
AU668157B2 (en)	1996-04-26
NZ251658A (en)	1996-08-27
CA2133440A1 (en)	1993-10-14
JPH07505398A (ja)	1995-06-15
MX9301939A (es)	1994-08-31
KR950700746A (ko)	1995-02-20
WO1993019758A1 (en)	1993-10-14

Similar Documents

Publication	Publication Date	Title
AU6393896A (en)	1997-01-30	Method for treating benign prostatic hyperplasia with thermal therapy
AU9214398A (en)	1999-05-31	Compositions and methods for treating water
HUP0001454A3 (en)	2002-01-28	Compositions and methods for treating plants with exogenous chemicals
AU1296099A (en)	1999-05-24	Methods and compositions for treating dermatoses
ZA97860B (en)	1997-08-04	Skin smoothing compositions containing hydroxyacids and methods for using same.
EP0650844A3 (de)	1996-04-03	Schwingrahmendrucker und Betriebsverfahren.
IL189132A0 (en)	2008-06-05	Pharmaceutical compositions for the treatment of prostate hypertrophy and prostate cancer
AU1316000A (en)	2000-05-15	Compositions and methods for treating benign prostatic hyperplasia using tocotrienols
GB2294465A8 (en)	1996-05-28	Perfluoroelastomeric compositions and methods
PH31545A (en)	1998-11-03	Inhibition of helicobacter.
ZA971964B (en)	1997-09-08	Azolobenzazepine derivatives and compositions and method of use thereof.
EP0640097A4 (de)	1997-01-15	Zusammensetzung und methoden zur impfung gegen coronaviren(20.01.94).
HU9501286D0 (en)	1995-06-28	Methods and compositions of (+) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis
EP0462668A3 (en)	1992-09-16	New 17beta-aminobenzoyl-4-aza-5alpha-androst-1-en-3-ones as benign prostatic hypertrophy agents
EP0633781A4 (de)	1995-04-19	Zusammensetzungen und verfahren zur behandlung der benignen prostatahypertropie.
GB2309990B (en)	2000-02-02	Compositions and processes for treating hydrocarbon-bearing formations
PL342339A1 (en)	2001-06-04	Novel substituted pyridino-aryl piperazines useful in treating benign prostatic hypertrophy
ZA989036B (en)	2000-04-05	Methods and compositions for treating rheumatoid arthritis.
AU9128998A (en)	1999-03-22	Composition and method for the treatment of benign prostatic hyperplasia and prostatitis
AU3720293A (en)	1993-09-03	Method and compositions for treating acne
AU5457694A (en)	1994-05-24	Methods and compositions of (-) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis
HK1012275A (en)	1999-07-30	Compositions and methods for treating benign prostatic hypertrophy
EP0737204A4 (de)	1999-06-23	CS - 1 Peptidmimetika, Zusammensetzunge und Methoden ihrer Anwendung
IL122316A0 (en)	1998-04-05	Melatonin agonists for treating benign prostatic hyperplasia
ZA978162B (en)	1998-03-03	Means for treating prostate hypertrophy and prostate cancer.

Legal Events

Date	Code	Title	Description
1994-12-02	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
1995-01-18	17P	Request for examination filed	Effective date: 19941011
1995-01-18	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
1995-04-19	A4	Supplementary search report drawn up and despatched	Effective date: 19950302
1995-04-19	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
1998-05-13	17Q	First examination report despatched	Effective date: 19980326
1999-01-15	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
1999-03-03	18D	Application deemed to be withdrawn	Effective date: 19980806
2005-11-11	REG	Reference to a national code	Ref country code: HK Ref legal event code: WD Ref document number: 1012275 Country of ref document: HK